ARTICLE | Clinical News
Genelabs presents Phase III data for GL701 Aslera
October 30, 2000 8:00 AM UTC
GNLB announced data from a Phase III trial of Aslera to treat systemic lupus erythematosus (SLE) in women at the American College of Rheumatology Annual Scientific Meeting. Among 119 patients, the GL7...